PRCT logo

PRCT PROCEPT BioRobotics Corporation

NASDAQ Global Market · Medical - Devices · Healthcare

$22.37
+1.75 (+8.49%)

PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate…

Market Cap: $1.28Bwww.procept-biorobotics.com

Price

$21.65-61.78%
$16.69$31.15$45.60$60.06
Jul 2025Aug 2026

Social Signal Score

51
5d
50
1 mentions
+0.0%
30d
57
3 mentions
+0.0%
60d
54
5 mentions
+0.0%
90d
41
8 mentions
+0.0%
news: 8

Analyst Ratings

17 analysts
Buyconsensus
Strong Buy 0Buy 9Hold 7Sell 1Strong Sell 0
Avg price target$23+2.8%
Low $19Median $21High $30
Current Consensus

52-week range

$16.69$41.59
Last close
$21.65
Off 52w high
-47.9%
200-day average
$26.84
vs 200-day
-19.4%

Compare with other stocks off their highs

Revenue

$98.29M+8128.63%
$1.19M$33.56M$65.93M$98.29M
Mar 2020Sep 2026

Analyst Estimates

FY2025
$-1.53
$-1.56–$-1.48
8 analysts
FY2026
$-1.71
$-1.76–$-1.68
7 analysts
FY2027
$-1.17
$-1.29–$-0.79
8 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Larry L. Wood
Sector
Healthcare
Industry
Medical - Devices
Employees
888
Beta
0.84
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
4.00
www.procept-biorobotics.com